Clinical Informatics Symposium
Friday 2nd December 2022
RMIT University
Register here!
The 3rd edition of the Clinical Informatics Symposium will be a full day event and will take place alongside the annual ABACBS Conference 2022.
Clinical Informatics (CI) is a fast-growing field in Australia, with applications across multiple areas of expertise such as genomics data analysis, bioinformatics, software development, data science and engineering, and clinical data analytics - all with the shared goal of improving health outcomes in patients.
This year’s symposium will focus on three main fields: Cancer Genomics, Rare Diseases, and for the first time, Pathogen Genomics. Each theme will be addressed by a keynote speaker, short talks selected from abstracts, and a discussion panel - where experts in the field will provide insight into the latest applications and career opportunities.
Target Audience
This symposium will be of interest to those bioinformaticians or data specialists that work in a hospital, pathology, or translational research setting, where the major focus is on interpreting data to improve health outcomes.
Organising Committee
- Mark Cowley (Computational Biology, Group Leader, Children’s Cancer Institute, Sydney NSW)
- Roxane Legaie (Clinical Bioinformatics Team Leader at the Peter MacCallum Cancer Centre – Pathology Department, Melbourne, VIC)
Ticket Pricing
The registration site and all ticket prices can be found here.
Program Structure
Each Session: 1 h 30 mins
Talks: 1h10 mins
Panels: 20 mins
Sessions
Start
End
Welcome
Mark Cowley
9:00 AM
9:05 AM
Theme 1 - Rare Diseases
Chair: Roxane Legaie
9:05 AM
10:35 AM
- Keynote speaker - Melanie Bahlo - The interplay between research and clinical genomics
- Abstract speaker #1: Simon Sadedin - Translation of RNASeq for Clinical Diagnosis of Rare Genetic Disorders
- Abstract speaker #2: TBA
- 20m Small panel (incl. questions)
Coffee break
10:35 AM
11:00 AM
Theme 2 - Pathogens
Chair: Mark Cowley
11:00 AM
12:30 PM
- Keynote speaker - David Wood - The tiger and the jungle: Harnessing clinical metagenomics to enable pathogen detection and therapeutic discovery
- Abstract speaker #1: Naveen Vankadari - Computational approaches in structural mechanism of SARS-CoV-2 entry and screening potential interventions
- Abstract speaker #2: Laurence Wilson - Cloud-INSIDER: fast and scalable detection of DNA integration
- 20m Small panel (incl. questions)
Lunch
12:30 PM
1:30 AM
Theme 3 - Cancer
Chair: Roxane Legaie
11:00 AM
12:30 PM
- Keynote speaker - Paul Wang - Cancer genomics: from research to clinical
- Abstract speaker #1: Chelsea Mayoh - Value of RNA-sequencing in precision medicine expands beyond fusion detection
- Abstract speaker #2: Sebastian Hollizeck - MisMatchFinder: Detection of somatic mutation signatures from low coverage WGS
- 20m Small panel (incl. questions)
Closing Remarks - Mark Cowley
3:00 PM
3:05 PM
Afternoon tea/ Farewell
3:05 PM
3:30 AM
Keynote Speakers
- Prof Melanie Bahlo:
Professor Melanie Bahlo is the Walter and Eliza Hall Institute’s “Healthy Development and Ageing” Theme Leader and holds an NHMRC Investigator grant.
She leads a bioinformatics/statistical genetics laboratory focused on understanding the genetic risk factors of neurological and retinal disorders.
The lab has interests in biological phenomena such as repeat expansions, RNA editing and somatic mutations. Although a predominantly genomics focused lab the lab also makes use of metabolomic and transcriptomic data, using genomics to guide discovery. The Bahlo lab has developed multiple tools and pipelines used worldwide for the discovery of genetic risk factors.
- Dr David Wood:
Dr David Wood leads the development of bioinformatic tools and the data production platform at Microba, providing fast-turnaround, cloud-based metagenomic results for consumer, practitioner, research and clinical samples. Dr Wood specialises in genome informatics and cloud-based scientific software development and has 20 years’ experience in both commercial and academic organisations. He is an author on more than 35 scientific publications. His primary interest is in the application and advancement of high-throughput genomics technologies to improve public health.
- Paul Wang:
- Paul Wang is a bioinformatics fellow working at the ACRF Cancer Genomics Facility at the Centre for Cancer Biology and SA Pathology. Paul has background in physics and mathematics, but got started in NGS bioinformatics after returning to Australia after a postdoc at the University of Chicago (Ecology & Evolution). He is very keen in clinical translation, and hopes to help bringing exciting cancer research findings and new technologies into clinical settings.
